Shumak K H, Rachkewich R A, Beldotti L E
Br J Haematol. 1979 Mar;41(3):407-11. doi: 10.1111/j.1365-2141.1979.tb05874.x.
Leukaemic blast cells were obtained from the blood of six patients with acute lymphoblastic leukaemia (ALL) and 15 patients with acute myeloblastic leukaemia (AML). The blasts were compared with lymphocytes from normal subjects in cytotoxicity and 125I-labelled antibody binding tests using several examples of anti-i. As much i antigen was detected on ALL blasts as on normal lymphocytes; much less i antigen was detected on AML blasts. Studies of three patients with morphologically undifferentiated acute leukaemia suggest that, in tests with anti-i, blasts from such patients react either like lymphoblasts or myeloblasts despite the absence of the corresponding morphological features.
白血病原始细胞取自6例急性淋巴细胞白血病(ALL)患者和15例急性髓细胞白血病(AML)患者的血液。在细胞毒性试验以及使用几种抗-i抗体的¹²⁵I标记抗体结合试验中,将这些原始细胞与正常受试者的淋巴细胞进行了比较。在ALL原始细胞上检测到的i抗原与正常淋巴细胞上的一样多;而在AML原始细胞上检测到的i抗原则少得多。对3例形态学上未分化的急性白血病患者的研究表明,在抗-i试验中,这些患者的原始细胞尽管缺乏相应的形态学特征,但反应要么像淋巴母细胞,要么像髓母细胞。